IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

ULIANO, JACOPO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.306
AS - Asia 855
NA - Nord America 678
SA - Sud America 128
AF - Africa 33
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.017
Salva come PNG Salva come JPEG
Nazione #
DE - Germania 608
US - Stati Uniti d'America 608
IT - Italia 243
CN - Cina 235
SG - Singapore 201
BR - Brasile 88
IN - India 79
SE - Svezia 77
VN - Vietnam 77
FR - Francia 72
HK - Hong Kong 72
GB - Regno Unito 70
BD - Bangladesh 52
RU - Federazione Russa 49
ES - Italia 43
CA - Canada 38
JP - Giappone 28
NL - Olanda 27
MX - Messico 25
TR - Turchia 24
CH - Svizzera 23
ID - Indonesia 21
FI - Finlandia 17
IE - Irlanda 15
PL - Polonia 15
BE - Belgio 14
KR - Corea 13
TW - Taiwan 11
AR - Argentina 10
AU - Australia 9
CO - Colombia 8
LB - Libano 8
EG - Egitto 7
GR - Grecia 7
NZ - Nuova Zelanda 7
PK - Pakistan 7
TN - Tunisia 7
CL - Cile 6
PH - Filippine 6
VE - Venezuela 6
DZ - Algeria 5
CI - Costa d'Avorio 4
HR - Croazia 4
MY - Malesia 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
EC - Ecuador 3
HU - Ungheria 3
JM - Giamaica 3
PT - Portogallo 3
RO - Romania 3
SD - Sudan 3
IL - Israele 2
IR - Iran 2
KE - Kenya 2
LU - Lussemburgo 2
MA - Marocco 2
PA - Panama 2
SA - Arabia Saudita 2
TH - Thailandia 2
UA - Ucraina 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AP - ???statistics.table.value.countryCode.AP??? 1
BO - Bolivia 1
GI - Gibilterra 1
GT - Guatemala 1
IQ - Iraq 1
JO - Giordania 1
KZ - Kazakistan 1
MD - Moldavia 1
OM - Oman 1
PY - Paraguay 1
SC - Seychelles 1
SR - Suriname 1
TT - Trinidad e Tobago 1
Totale 3.017
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 557
Ashburn 98
Singapore 94
Hong Kong 59
Milan 51
Santa Clara 34
San Jose 33
Chandler 31
Beijing 29
Los Angeles 26
Rome 25
Council Bluffs 24
Dallas 24
Hanoi 24
Hefei 24
New York 22
Shanghai 19
Bengaluru 17
Ho Chi Minh City 15
Bologna 14
Helsinki 14
Hyderabad 14
Lauterbourg 14
Southend 14
Moscow 13
Florence 12
Chennai 11
Dublin 11
Madrid 11
São Paulo 11
Toronto 11
Boston 10
Buffalo 10
London 10
Cambridge 9
Munich 9
Princeton 9
Barcelona 8
Gdansk 8
Jakarta 8
Mexico City 8
Montreal 8
Bari 7
Brussels 7
Istanbul 7
Oldham 7
Rio de Janeiro 7
Tokyo 7
Ahmedabad 6
Ann Arbor 6
Boardman 6
Cairo 6
Chicago 6
Denver 6
Guangzhou 6
Paris 6
Valencia 6
Ancona 5
Cangzhou 5
Cologne 5
Lanester 5
Naples 5
Santiago 5
Shenzhen 5
Sydney 5
Taipei 5
Tunis 5
Turin 5
Vancouver 5
Verona 5
Washington 5
Abidjan 4
Aracaju 4
Brescia 4
Chapel Hill 4
Cuauhtémoc 4
Hangzhou 4
Kaohsiung 4
Lausanne 4
Nanjing 4
Porto Alegre 4
Salvador 4
Stockholm 4
Warsaw 4
Abiko 3
Algiers 3
Amsterdam 3
Arezzo 3
Auckland 3
Azuqueca de Henares 3
Basel 3
Belo Horizonte 3
Bern 3
Bloomfield 3
Bogotá 3
Boves 3
Brasília 3
Brisbane 3
Budrio 3
Campo Grande 3
Totale 1.719
Salva come PNG Salva come JPEG
Nome #
Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer : a systematic review 764
Margetuximab for the treatment of HER2-positive metastatic breast cancer 533
Systemic Treatment of Ductal Carcinoma In Situ of the Breast 237
The Immune-related adverse event (IRAE) Likelihood Score (ILS) identifies “pure” IRAEs strongly associated with outcome in a phase I-II trial population 227
A set of easy and stringent criteria to identify immune-related adverse events (IrAE Scoring System, ISS) improves correlation with outcome in a phase 1-2 trial population 191
First line treatment of BRAF mutated advanced melanoma: Does one size fit all? 181
SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis 171
Characterization of low HER2 expressions in de-novo metastatic breast cancer 158
Clinical development and current role of margetuximab for the treatment of breast cancer 158
Immune-related adverse events are correlated with significantly improved outcome in a phase I trial population exposed to combination immunotherapy 157
Immune-Related Adverse Event Likelihood Score Identifies “Pure” IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population 118
MET in Non-Small-Cell Lung Cancer (NSCLC): Cross ‘a Long and Winding Road’ Looking for a Target 113
Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials 61
Totale 3.069
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.139
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.139
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 5 18
2021/2022118 6 6 6 4 6 4 1 15 25 17 15 13
2022/2023353 19 25 41 33 29 26 22 28 43 21 47 19
2023/2024749 27 30 17 46 71 42 101 84 52 79 96 104
2024/2025751 82 84 76 78 54 43 15 67 37 65 69 81
2025/20261.069 121 101 105 93 79 49 145 46 122 74 134 0
Totale 3.069